Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Influence of ABO locus on PFA-100 collagen-ADP closure time is not totally dependent on the von willebrand factor. Results of a GWAS on gait-2 project phenotypes

  • Pujol-Moix, N.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Llobet, D.
  • Vilalta, N.
  • Hamsten, Anders|||0000-0002-0618-0538
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
(1) Background: In a previous study, we found that two phenotypes related to platelet reactivity, measured with the PFA-100 system, were highly heritable. The aim of the present study was to identify genetic determinants that influence the variability of these phenotypes: Closure time of collagen-ADP (Col-ADP) and of collagen-epinephrine (Col-Epi). (2) Methods: As part of the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia (2) Project, 935 individuals from 35 large Spanish families were studied. A genome-wide association study (GWAS) with ≈ 10 M single nucleotide polymorphisms (SNPs) was carried out with Col-ADP and Col-Epi phenotypes. (3) Results: The study yielded significant genetic signals that mapped to the ABO locus. After adjusting both phenotypes for the ABO genotype, these signals disappeared. After adjusting for von Willebrand factor (VWF) or for coagulation factor VIII (FVIII), the significant signals disappeared totally for Col-Epi phenotype but only partially for Col-ADP phenotype. (4) Conclusion: Our results suggest that the ABO locus exerts the main genetic influence on PFA-100 phenotypes. However, while the effect of the ABO locus on Col-Epi phenotype is mediated through VWF and/or FVIII, the effect of the ABO locus on Col-ADP phenotype is partly produced through VWF and/or FVIII, and partly through other mechanisms.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The TAGA Study, a Study of Factors Determining Aortic Diameter in Families at High Risk of Abdominal Aortic Aneurysm Reveal Two New Candidate Genes

  • Peypoch, Olga|||0000-0002-9795-5553
  • Paüls-Vergés, Ferran
  • Vázquez-Santiago, Miquel|||0000-0002-9432-4297
  • Dilmé, Jaume|||0000-0003-0127-0064
  • Romero, José
  • Giner, Jordi|||0000-0002-3044-2059
  • Plaza, Vicente|||0000-0003-2567-5496
  • Escudero, José Román|||0000-0003-3929-6403
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
A variety of disorders are known to be related with aortic geometry, among them abdominal aortic aneurysm (AAA). This work aims to present the main determinants of abdominal aortic diameter in a new cohort of families at high risk of AAA. The Triple-A Genomic Analysis (TAGA) study comprises 407 individuals related in 12 families. Each family was collected through a proband with AAA. We calculated heritability and genetic correlations between abdominal aortic diameter and clinical parameters. A genome-wide linkage scan was performed based on 4.6 million variants. A predictive model was calculated with conditional forest. Heritability of the abdominal aortic diameter was 34%. Old age, male sex, higher height, weight, creatinine levels in serum, and better lung capacity were the best predictors of aortic diameter. Linkage analyses suggested the implication of Epidermal Growth Factor Receptor (EGFR) and Betacellulin (BTC) genes with aortic diameter. This is the first study to evaluate genetic components of variation of the aortic diameter in a population of AAA high-risk individuals. These results reveal EGFR, a gene that had been previously implicated in AAA, as a determinant of aortic diameter variation in healthy genetically enriched individuals, and might indicate that a common genetic background could determine the diameter of the aorta and future risk of AAA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk

  • López, Sonia|||0000-0002-5023-5153
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Rodriguez-Rius, Alba
  • Viñuela, Ana|||0000-0003-3771-8537
  • Brown, Andrew A.
  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Vilalta, Noelia|||0000-0002-3961-3563
  • Arús, Marc
  • Panousis, Nikolaos I.
  • Buil, Alfonso|||0000-0002-3097-1014
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Dermitzakis, Emmanouil T.|||0000-0002-9302-6490
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Plasma cell-free DNA (cfDNA) is a surrogate marker of neutrophil extracellular traps (NETs) that contribute to immunothrombosis. There is growing interest about the mechanisms underlying NET formation and elevated cfDNA, but little is known about the factors involved.We aimed to identify genes involved in the regulation of cfDNA levels using data from the Genetic Analysis of Idiopathic Thrombophilia (GAIT-2) Project. Imputed genotypes, whole blood RNA-Seq data, and plasma cfDNA quantification were available for 935 of the GAIT-2 participants from 35 families with idiopathic thrombophilia. We performed heritability and GWAS analysis for cfDNA. The heritability of cfDNA was 0.26 (p 3.7106), while the GWAS identified a significant association (rs1687391, p 3.551010) near the ORM1 gene, on chromosome 9. An eQTL (expression quantitative trait loci) analysis revealed a significant association between the lead GWAS variant and the expression of ORM1 in whole blood (p 6.14109). Additionally, ORM1 expression correlated with levels of cfDNA (p 4.38104). Finally, genetic correlation analysis between cfDNA and thrombosis identified a suggestive association (?g 0.43, p 0.089). All in all, we show evidence of the role of ORM1 in regulating cfDNA levels in plasma, which might contribute to the susceptibility to thrombosis through mechanisms of immunothrombosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antithrombin, protein C, and protein S, genome and transcriptome-wide association studies identify 7 novel loci regulating plasma levels

  • Ji, Yuekai
  • Temprano Sagrera, Gerard|||0000-0001-6136-8915
  • Holle, Lori|||0000-0003-1399-2689
  • Bebo, Allison
  • Brody, Jennifer A.|||0000-0001-8509-148X
  • Le, Ngoc-Quynh
  • Kangro, Kadri|||0000-0003-1808-6386
  • Brown, Michael R.|||0000-0002-5235-9037
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Sitlani, Collen M.|||0000-0001-7656-7482
  • Suchon, Pierre
  • Kleber, Marcus E.|||0000-0003-0663-7275
  • Emmert, David B.
  • Ozel, Ayse Bilge
  • Dobson, DreVon|||0000-0001-5123-5473
  • Tang, Weihong|||0000-0003-1200-0270
  • Llobet, Dolors
  • Tracy, Russell|||0000-0002-0080-2420
  • Deleuze, Jean-François
  • Delgado, Graciela E.|||0000-0002-1272-7210
  • Gögele, Martin|||0000-0003-4785-4348
  • Wiggins, Kerri L.|||0000-0003-2749-1279
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Pankow, James S.|||0000-0001-7076-483X
  • Taylor, Kent|||0000-0002-2756-4370
  • Trégouët, David-Alexandre|||0000-0001-9084-7800
  • Moissl, Angela Patricia|||0000-0003-0302-2136
  • Fuchsberger, Christian|||0000-0002-5918-8947
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Morrison, Alanna|||0000-0001-6381-4296
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Cushman, Mary|||0000-0002-7871-6143
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • März, Winfried|||0000-0001-6083-8946
  • Hicks, Andrew A.|||0000-0001-6320-0411
  • Desch, Karl C.
  • Johnson, Andrew|||0000-0001-6369-5178
  • de Vries, Paul S.|||0000-0003-0964-0111
  • Wolberg, Alisa S.|||0000-0002-2845-2303
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
Background: Antithrombin, PC (protein C), and PS (protein S) are circulating natural anticoagulant proteins that regulate hemostasis and of which partial deficiencies are causes of venous thromboembolism. Previous genetic association studies involving antithrombin, PC, and PS were limited by modest sample sizes or by being restricted to candidate genes. In the setting of the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, we meta-analyzed across ancestries the results from 10 genome-wide association studies of plasma levels of antithrombin, PC, PS free, and PS total. Methods: Study participants were of European and African ancestries, and genotype data were imputed to TOPMed, a dense multiancestry reference panel. Each of the 10 studies conducted a genome-wide association studies for each phenotype and summary results were meta-analyzed, stratified by ancestry. Analysis of antithrombin included 25 243 European ancestry and 2688 African ancestry participants, PC analysis included 16 597 European ancestry and 2688 African ancestry participants, PSF and PST analysis included 4113 and 6409 European ancestry participants. We also conducted transcriptome-wide association analyses and multiphenotype analysis to discover additional associations. Novel genome-wide association studies and transcriptome-wide association analyses findings were validated by in vitro functional experiments. Mendelian randomization was performed to assess the causal relationship between these proteins and cardiovascular outcomes. Results: Genome-wide association studies meta-analyses identified 4 newly associated loci: 3 with antithrombin levels (GCKR, BAZ1B, and HP-TXNL4B) and 1 with PS levels (ORM1-ORM2). transcriptome-wide association analyses identified 3 newly associated genes: 1 with antithrombin level (FCGRT), 1 with PC (GOLM2), and 1 with PS (MYL7). In addition, we replicated 7 independent loci reported in previous studies. Functional experiments provided evidence for the involvement of GCKR, SNX17, and HP genes in antithrombin regulation. Conclusions: The use of larger sample sizes, diverse populations, and a denser imputation reference panel allowed the detection of 7 novel genomic loci associated with plasma antithrombin, PC, and PS levels.